Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
Piśmiennictwo
1.
SherlockS.Hepaticencephalopathy:Historicalreviewupto1975.W:RecordC.,
Al-MardiniH.(red.).Advancesinhepaticencephalopathyandmetabolisminliver
diseases.IpswichBookCompanyLtd,1997:159-163.
2.
MorgagniG.B.Desedibusetcausismorborumperanatomenindagatis.Typographia
Remondiniana,Venice1761.
3.
FrerichsF.T.Aclinicaltreatiseondiseasesoftheliver.Tom1.NewSydenhamSociety,
London1861.
4.
HahnM.,MassenO.,NenckiM.iwsp.DieEck’schefstelzwischenderunterenhohlvene
undderpfortaderundihrefolgenfurdenorganismus.Arch.Exp.Pathol.Pharm.
1893;32:161-210.
5.
VanCaulertC.,DevillerC.,HalffM.Troublesprovoquesparl’ingestiondesels
ammoniacauxchezl’hommeatteintdecirrhosedeLaennec.ComptesRendusSoc.
Biol.1932;111:739-740.
6.
KirkE.Aminoacidandammoniametabolisminliverdisease.ActaMed.Scand.
1936;suppl.77:1-147.
7.
PhillipsG.B.,SchwartzR.,GabuzdaG.iwsp.Thesyndromeofimpendinghepaticcoma
inpatientswithcirrhosisofthelivergivencertainnitrogenoussubstances.N.Engl.J.Med.
1952;247:239-246.
8.
SherlockS.,SummerskillW.H.J.,WhiteL.P.iwsp.Portal-systemicencephalopathy.
Neurologicalcomplicationsofliverdisease.Lancet.1954;267:453-457.
9.
FazekasJ.E,TicktinH.E.,SheaJ.G.EffectsofL-arginineonhepaticencephalopathy.
Am.J.Med.Sci.1957;234:462-467.
10.
RikkersL.,JenkoP.,RudmanD.iwsp.Subclinicalhepaticencephalopathy:detection,
prevalence,andrelationshiptonitrogenmetabolism.Gastroenterology.1978;75:462-469.
11.
DawsonA.M.,McLarenJ.,SherlockS.Neomycininthetreatmentofhepaticcoma.
Lancet.1957;2:1263-1268.
12.
ButterworthRF.Progressinhepaticencephalopathyandmetabolicnitrogenexchange.
CRCPress,1990:9-24.
13.
AlbrechtH.,NorenbergM.D.Glutamine:aTrojanhorseinammonianeurotoxicity.
Hepatology.2006;44:788-794.
14.
WrightG.,JalenR.Ammoniaandinflammationinthepathogenesisofhepatic
encephalopathy:Pandora’sbox?Hepatology.2007;46:291-294.
15.
WalsheJ.M.Observationsonthesymptomatologyandpathogenesisofhepaticcoma.
Quart.J.Med.1951;20:421-438.
16.
SherlockS.,SummerskillW.H.J.,DawsonA.M.Thetreatmentandprognosisofhepatic
coma.Lancet.1956;2:689-694.
17.
BircherJ.,MullerJ.,GuggenheimP.Treatmentofchronicportal-systemicencephalopathy
withlactulose.Lancet.1966;1:890-892.
18.
TreyC.,BurnsD.G.,SaundersS.J.Treatmentofhepaticcomabyexchangeblood
transfusion.N.Engl.J.Med.1966;274:473-481.
19.
JonesE.A.,ClainD.,ClineH.M.iwsp.Hepaticcomaduetoacutehepaticnecrosis
treatedbyexchangebloodtransfusion.Lancet.1967;2:169-172.
20.
ParbhooS.P.,KennedyJ.,JamesI.M.iwsp.Extra-corporealpig-liverperfusion
intreatmentofhepaticcomaduetofulminanthepatitis.Lancet.1971;1:659-665.
21.
SabinS.,MerrittJ.A.Treatmentofhepaticcomaincirrhosisbyplasmapheresis
andplasmainfusion(plasmaexchange).Ann.Intern.Med.1968;68:1-7.
22.
BorońP.,FlisiakR.,BobrowskaE.iwsp.Plasmapheresisandaminoacidmixtures
ofnAminosteril-Hepa”typepreparationsintreatinghepaticencephalopathy.
Pol.Tyg.Lek.1991;46:984-986.
PIŚMIENNICTWO
